.Juan I . Sotos. Uepts of Peds and >led.. College of Medicine, The Ohio State University and Children's Hospital, Columbus, Ohio.
Gastric Inhibitory polypeptide (CII') given intravenously with glucose potentiates insulin secretion and improves glucose tolerance. Since patients with growth hormone (GH) deficiency frequently show alterations in oral glucose tolerance (GTT) and ma) have low insulin levels, the secretion of GIP in hypopituitary patients before and after GH administration for 6 months was studied. Glucose, insulin and GIP levels were obtained during ar oral CTT. Ihe results are expressed as +the standard error of mean. 'Time (min) 0 15 30 60 120 GII'(pg/ml) P r e G H 378+72 -809568 8 0 9 5 7 750592 7802100 I'ost Gll 306269 6775118 745~123 6 7 7 9 5 6 2 3~9 1 Insulin Pre Gli 5.33.5 2 9~6 3 4 9 3 3~1 1 2156 (pU/ml) Post (;ll 5.65.5
?0+5 -31+8 31210 1954 'There was no significant difference in the response of GIP, ~nsulin, or glucose to an oral G'l'T before and after 6 months of GI1 administration (2 units Im 3 times weekly). The levels of GIP ;ire comparable to normal controls suggesting no impaired secretlon of GII' in growth hormone deficiency. It does not appear that GI!' ploys a role in the carbohydrate abnormalities in growth hormone deficienc (Supported in part by {he .John W. Champion Center.)
2 sisters, 3 (sib I) and 7 (sib 11) years old, from consanguineou and normal parents, presented with active rickets, skeletal deformities and alopecia totalis after years of vitamin (vit) D, therapy (50,000 IU/d). Representative levels in serum for sib I and 11, respectively, were Ca, mg/dl: 9.8, 8.9; P, mg/dl: 4.0, 2.0; 25-OHD, ng/ml: 47, 42 (normal 2725);parathyroid hormone (PTIO, p1-eq/L: 42, 44 (normal = < 40); 1,25(OH),D3, pg/ml, was >m(normal=fi) in both sibs. Both sibs had a calcemicresponsc to PTH: tCa by 1.3 and Z.lmg/dl andnormal renal responses (P and CAMP) to PTH. The TRP in both was 77-80%. The mean balances,mg/c in sib I for Ca was -55 and for P-95,while in sib I1 the value for Ca was -140 and for P-190. 1,25(OH),D3 treatment at doses of .04 and .06dg/kg/d (.50pgand .75+1g/d) failed to reverse the Thcse 2 sibs have a new inborn error of vit g metabolism arked by intestinal end-organ unresponsiveness to supranormal alabsorption of Ca and P and rickets. Also, both sibs have yporesponsiveness to 1,25(OH),D3 at bone in view of normoalcemia despite extremely high 1,25(OH),D, and slightly elevate TH levels in serum.
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SHEEP FETUS. C.A. Sklar, P.L. Mueller, P.D. Gluckman, evels of FSH and LH in mid-gestation. Higher T levels in males p to 130d most likely reflects fetal testicular activity and may xplain the lower FSH in the male. The fall in gonadotropins in 0th sexes in late gestation may be a consequence of increasing vpothalamic-pituitary sensitivity to circulatin~ sex steroids. Women, Boston, MA 02115. Long-term reproductive and gonadal steroid potential has been investigated in 10 female patients (pts) who were treated for a variety of abdominal malignancies before puberty. All pt presented with complaints of primary amenorrhea and lack of development of secondary sexual characteristics while off therapy and free of extant disease for 1-23 years. Evaluation consisted of assessment of pubertal development according to Tanne and by double antibody radioimunoassay of serum gonadotropins according to Odell. All pts demonstrated significantly elevate serum gonadotropins indicative of ovarian failure: 24 mIU/ml tc 85 mIU/ml LH and 78 mIU/ml to 156 mIU/ml FSH, with FSH consistently elevated above LH. The pts had been treated with betwee 1790-5500 rad to the abdomen and/or pelvis in fractionated dose as well as one or a combination of chemotherapeutic agents including vincristine, methotrexate, cyclophosphamide, actinomyci D or chlorambucil. Improved long-term survivorship from prepubertal malignancies necessitates consideration of future ovaria steroidal and reproductive function in therapeutic regimes. Evaluation of other pts to attempt to separate the effects of radio-and chemotherapy on gonadal function, as well as assessment of the effects of replacement estrogen therapies is The newborn male with salt-losing CAH is at risk for mortality before recognition of the disease. To better define the clinical features of CAH in the newborn period, we have reviewed the records of 45 children with CAH diagnosed before age 4 weeks In 14 of 27 (52%) families with older children there was a history of early death of a male infant. Affected infants had significantly greater birth length and birth weight than a group of 66 control term infants, and their upper-to-lower segment ratio (UII.) was significantly lower than that found in controls.
CONTROLS In 17 of 19 salt-losing infants the initial sign of a metabol abnormality was a decline in C02 content. Urinary 17-Ketosteroid excretion rose progressively from admission to initiation of therapy, but urinary Pregnanetriol excretion was uniformly low in the first week of life and did not permit distinction between different forms of CAH. The large for dat male infant with a low upper-to-lower segment ratio merits early diagnostic evaluation for CAH despite a negative family history of unexplained neonatal deaths.
Pittsburgh School of Medicine, Pittsburgh, PA. To evaluate the possibility that adrenal androgens effect hy pothalamic-~ituitarv maturation and the onset of puberty, sev---era1 groups of patients have been studied who had increased or decreased adrenal androgens for age: 11 40 female patients with premature adrenarche were followed; 15% progressed to sexual precocity; in the other 85% the mean age + SD of the onset of breast development and menarche was available for 21 (9.7 + 1.3 and 17 (10.7 + 1.4) subjects respectively. 2 / The mean a g e o f the onset of puberty among 5 male patients with Addison's disease who were well-nourished and adequately treated was 12.3 + 0.3 years. 3/ Mean levels of 24 hr integrated concentrations (ng/100 ml) of testosterone (T), androstenedione (A), 17-hydro3 progesterope (170HP). progesterone (P) and dehydroepiandrosterone (DHA) in 3 patients with Addison's disease, agonadal males, normal Dubertal males were:
---. 
